mSphere:研究发现谷胱甘肽在铜绿假单胞菌的毒力中发挥关键作用

2018-05-16 MedSci MedSci原创

铜绿假单胞菌是一种无处不在的革兰氏阴性细菌,可导致严重的机会性感染。该菌使用的主要氧化还原缓冲液是谷胱甘肽(GSH)。为了评估GSH在铜绿假单胞菌毒力中的作用,使用缺少gshA的突变菌株进行了许多分析,该菌株不产生GSH。 结果显示,与野生型菌株相比,突变菌株在基本培养基中表现出生长延迟。此外,gshA突变体在生物膜和残留细胞形成以及游动和群集运动性方面存在缺陷,并关键毒力因子绿脓素的水平降低。最

铜绿假单胞菌是一种无处不在的革兰氏阴性细菌,可导致严重的机会性感染。该菌使用的主要氧化还原缓冲液是谷胱甘肽(GSH)。为了评估GSH在铜绿假单胞菌毒力中的作用,使用缺少gshA的突变菌株进行了许多分析,该菌株不产生GSH。

结果显示,与野生型菌株相比,突变菌株在基本培养基中表现出生长延迟。此外,gshA突变体在生物膜和残留细胞形成以及游动和群集运动性方面存在缺陷,并关键毒力因子绿脓素的水平降低。最后,gshA突变株表明对甲基紫精(氧化还原循环剂)以及巯基反应性抗生素磷霉素和利福平的敏感性增加。

总之,这些数据表明GSH在铜绿假单胞菌毒力中发挥关键作用。

原始出处:


Tricia A. Van Laar, Saika Esani, et al., Pseudomonas aeruginosa gshA Mutant Is Defective in Biofilm Formation, Swarming, and Pyocyanin Production. mSphere. 2018 Mar-Apr; 3(2): e00155-18. doi:  10.1128/mSphere.00155-18

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1753401, encodeId=0e741e5340106, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Mar 14 14:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315926, encodeId=3bf131592661, content=学习了谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 17 08:48:53 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315746, encodeId=ca4b315e4676, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Wed May 16 21:57:08 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315645, encodeId=b7b431564502, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed May 16 13:32:30 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315644, encodeId=46d831564404, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Wed May 16 13:01:44 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1753401, encodeId=0e741e5340106, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Mar 14 14:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315926, encodeId=3bf131592661, content=学习了谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 17 08:48:53 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315746, encodeId=ca4b315e4676, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Wed May 16 21:57:08 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315645, encodeId=b7b431564502, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed May 16 13:32:30 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315644, encodeId=46d831564404, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Wed May 16 13:01:44 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-17 lou.minghong

    学习了谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1753401, encodeId=0e741e5340106, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Mar 14 14:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315926, encodeId=3bf131592661, content=学习了谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 17 08:48:53 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315746, encodeId=ca4b315e4676, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Wed May 16 21:57:08 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315645, encodeId=b7b431564502, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed May 16 13:32:30 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315644, encodeId=46d831564404, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Wed May 16 13:01:44 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-16 一天没事干

    很好的学习机会

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1753401, encodeId=0e741e5340106, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Mar 14 14:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315926, encodeId=3bf131592661, content=学习了谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 17 08:48:53 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315746, encodeId=ca4b315e4676, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Wed May 16 21:57:08 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315645, encodeId=b7b431564502, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed May 16 13:32:30 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315644, encodeId=46d831564404, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Wed May 16 13:01:44 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-16 医者仁心5538

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1753401, encodeId=0e741e5340106, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Mar 14 14:33:00 CST 2019, time=2019-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315926, encodeId=3bf131592661, content=学习了谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 17 08:48:53 CST 2018, time=2018-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315746, encodeId=ca4b315e4676, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Wed May 16 21:57:08 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315645, encodeId=b7b431564502, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed May 16 13:32:30 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=315644, encodeId=46d831564404, content=学习了.涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Wed May 16 13:01:44 CST 2018, time=2018-05-16, status=1, ipAttribution=)]
    2018-05-16 王秀

    学习了.涨知识了!

    0

相关资讯

世界卫生组织《医疗机构耐碳青霉烯的肠杆菌科细菌、铜绿假单胞菌和鲍曼不动杆菌防控指南》介绍

耐碳青霉烯的肠杆菌科细菌、铜绿假单胞菌和鲍曼不动杆菌是医院感染的重要病原体,并在最近几年内广泛扩散。为预防和控制此类耐药菌在医疗机构内传播,2017 年世界卫生组织组织编写了《医疗机构耐碳青霉烯的肠杆菌科细菌、鲍曼不动杆菌和铜绿假单胞菌防控指南》。该文将从指南编写的背景、编写过程、主要防控措施、优缺点等方面进行介绍,希望能帮助广大感染预防和控制从业人员落实指南,切实降低这些多重耐药菌的医院感染。

Braz J Infect Dis:院内感染相关的铜绿假单胞菌生物膜形成分析

形成生物膜是铜绿假单胞菌存活的重要机制,并与其耐药性有关。铜绿假单胞菌是一种常与医院感染有关的机会性病原体,尤其是在免疫不全的机体中。本研究旨在分析铜绿假单胞菌分离株中表型生物膜的产生,描述克隆谱,并分析群体感应(QS)基因和非生物膜产生菌株的LasR蛋白中突变的发生。通过测量细胞对微量滴定板的粘附来测试铜绿假单胞菌的生物膜形成。通过ERIC-PCR进行克隆谱分析,通过特异性PCR进行QS基因分析

Biofouling:耐热木聚糖酶可抑制和分解铜绿假单胞菌生物膜

铜绿假单胞菌生物膜是亟待解决的问题,由于其耐药性而在慢性感染持续存在中起关键作用。在此研究中,研究人员探究了各种细胞壁降解酶抑制两种铜绿假单胞菌菌株PAO1和PA14的生物膜形成的能力。结果显示,木聚糖酶可明显抑制和分离铜绿假单胞菌生物膜而不影响浮游生长。木聚糖酶处理破坏细胞外聚合物质并降低铜绿假单胞菌菌株的粘度。然而,木聚糖酶处理不改变pyochelin,绿脓素,pyoverdine,假单胞菌喹

2017 WHO指南:医疗卫生机构中耐碳青霉烯类肠杆菌,鲍曼不动杆菌和铜绿假单胞菌的预防和控制

2017年11月,世界卫生组织(WHO)发布了医疗卫生机构中耐碳青霉烯类肠杆菌,鲍曼不动杆菌和铜绿假单胞菌的预防和控制指南,本文主要针对医疗卫生机构中耐碳青霉烯类肠杆菌,鲍曼不动杆菌和铜绿假单胞菌感染的早期识别以及感染预防与控制提供循证建议。

NEJM:坏疽性深脓疱病-病例报道

坏疽性深脓疱病是由铜绿假单胞菌菌血症相关的皮肤感染所致。感染通常发生在免疫功能低下或危重病患者身上,需要及时诊断和治疗。

Eur Respir J:铜绿假单胞菌感染对支气管扩张症长期临床结局的独立影响!

由此可见,铜绿假单胞菌被发现与病情恶化、入院和生活质量较差有关。铜绿假单胞菌感染患者的死亡率增加,尤其是在频繁恶化的情况下。